Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription 06.06.2022 2 Anticancer Res 2 Biochem Biophys Res Commun 3 BMC Gastroenterol 21 Clin Res Hepatol Gastroenterol 1 Dig Dis 1 Dig Dis Sci 1 Endoscopy 2 Eur Radiol 1 J Clin Oncol 1 J Gastroenterol 5 J Hepatol 4 PLoS One 2 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. MATSUMURA K, Yamamura K, Oda E, Akahoshi S, et al
   Successful Treatment of Intrahepatic Cholangiocarcinoma With Liver/Lung Metastasis and Peritoneal Dissemination After Liver Resection.
   Anticancer Res. 2022;42:3209-3215.
   PubMed         Abstract available
   
   
2. HIDAKA M, Hara T, Soyama A, Sasaki R, et al
   The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience.
   Anticancer Res. 2022;42:3049-3054.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. GUO B, Xu X, Shao M, Yang X, et al
   UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
   Biochem Biophys Res Commun. 2022;613:207-213.
   PubMed         Abstract available
   
   
4. XU Y, Denning KL, Lu Y
   PPARalpha agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
   Biochem Biophys Res Commun. 2022;613:47-52.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. WU J, Tian S, Li H, Xu Z, et al
   Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.
   BMC Gastroenterol. 2022;22:265.
   PubMed         Abstract available
   
   
6. GAO FL, Wang Y, Huang XZ, Pan TF, et al
   I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma.
   BMC Gastroenterol. 2022;22:273.
   PubMed         Abstract available
   
   
7. LI J, Lu J, Lv S, Sun S, et al
   Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma.
   BMC Gastroenterol. 2022;22:269.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

8. JAIN A, Kirkpatrick RB, Sobotka LA
   Severe pruritis during pregnancy: More than just intrahepatic cholestasis of pregnancy?
   Clin Res Hepatol Gastroenterol. 2022;46:101875.
   PubMed        
   
   
9. LI L, Xin Y, Zhang X, Chen Y, et al
   The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.
   Clin Res Hepatol Gastroenterol. 2022;46:101878.
   PubMed         Abstract available
   
   
10. HOORNAERT E, Yombi JC, Coubeau L, Baldin P, et al
    Liver hypodense infectious lesions: Is it only bacteria, parasites or fungi?
    Clin Res Hepatol Gastroenterol. 2022;46:101872.
    PubMed        
    
    
11. KAPS L, Hildebrand K, Nagel M, Michel M, et al
    Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2022 Feb 3:101873.
    PubMed         Abstract available
    
    
12. WASUWANICH P, So JM, Scheimann AO, Spahic H, et al
    Hepatic and non-hepatic hydrothorax in pediatric ascites.
    Clin Res Hepatol Gastroenterol. 2022;46:101868.
    PubMed         Abstract available
    
    
13. ARTRU F, Moschouri E, Denys A
    Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2022;46:101858.
    PubMed         Abstract available
    
    
14. WANG H, He X, Fang D, Wang X, et al
    Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model.
    Clin Res Hepatol Gastroenterol. 2022;46:101853.
    PubMed         Abstract available
    
    
15. ZHANG S, Zhao Y, He L, Bo C, et al
    Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101851.
    PubMed         Abstract available
    
    
16. CANIVET CM, Smati S, Lannes A, Brisseau J, et al
    Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners.
    Clin Res Hepatol Gastroenterol. 2022;46:101848.
    PubMed         Abstract available
    
    
17. ZHU X, Lin X, Zhang P, Liu Y, et al
    Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study.
    Clin Res Hepatol Gastroenterol. 2022;46:101843.
    PubMed         Abstract available
    
    
18. ATHYROS VG, Katsiki N, Mikhailidis DP
    Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101842.
    PubMed        
    
    
19. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
    The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.
    Clin Res Hepatol Gastroenterol. 2021 Nov 20:101838.
    PubMed         Abstract available
    
    
20. ZHANG C, Zhang B, Chen A, Yin Q, et al
    Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-beta-mediated fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101833.
    PubMed         Abstract available
    
    
21. SHAHID A, Cheema HA
    Can statins finally provide the breakthrough in the treatment of non-alcoholic fatty liver disease?
    Clin Res Hepatol Gastroenterol. 2022;46:101826.
    PubMed        
    
    
22. MOGA L, Robic MA, Blasco-Perrin H, Cabarrou P, et al
    Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients.
    Clin Res Hepatol Gastroenterol. 2021 Oct 27:101822.
    PubMed         Abstract available
    
    
23. LYU T, Yao H, Wang J, Song L, et al
    Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus.
    Clin Res Hepatol Gastroenterol. 2022;46:101819.
    PubMed         Abstract available
    
    
24. FATIMA K, Moeed A, Waqar E, Atif AR, et al
    Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101816.
    PubMed         Abstract available
    
    
25. LONCAR Y, Tartrat N, Lastennet D, Lemoine L, et al
    Pulmonary infection after hepatic resection: Associated factors and impact on outcomes.
    Clin Res Hepatol Gastroenterol. 2022;46:101733.
    PubMed         Abstract available
    
    
26. THOMAS LS, Geoffroy V, Patrick C, Rodolphe A, et al
    Infectious complications of portal biliopathy leading to liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Feb 10:101879.
    PubMed        
    
    
27. ZHANG X, Jiang M, Zhang X, Zhang J, et al
    An extracellular matrix-based signature associated with immune microenvironment predicts the prognosis of patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101877.
    PubMed         Abstract available
    
    
28. SUN L, Deng C, Gu Y, He Y, et al
    Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Clin Res Hepatol Gastroenterol. 2022;46:101876.
    PubMed         Abstract available
    
    

    
    Dig Dis

29. CAO D, Liu H, Bai L, Tang H, et al
    EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma.
    Dig Dis. 2022 May 30. pii: 000525232. doi: 10.1159/000525232.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

30. AL-OBAID LN, Bazarbashi AN, Ryou M
    Variceal Bleeding: Beyond Banding.
    Dig Dis Sci. 2022;67:1442-1454.
    PubMed         Abstract available
    
    

    
    Endoscopy

31. YAMADA M, Hara K, Haba S, Mizuno N, et al
    Endoscopic ultrasound-guided hepaticogastrostomy using a novel drill dilator.
    Endoscopy. 2022 May 30. doi: 10.1055/a-1838-3682.
    PubMed        
    
    

    
    Eur Radiol

32. HUANG Z, Zhou P, Li S, Li K, et al
    Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08872.
    PubMed         Abstract available
    
    
33. MENG D, Liang C, Zheng Y, Wang X, et al
    The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08874.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

34. BEJJANI AC, Finn RS
    Hepatocellular Carcinoma: Pick the Winner-Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent-Based Combinations.
    J Clin Oncol. 2022 Jun 1:JCO2102605. doi: 10.1200/JCO.21.02605.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

35. ALI AH, Bi Y, Machicado JD, Garg S, et al
    The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    J Gastroenterol. 2020 Aug 8. pii: 10.1007/s00535-020-01714.
    PubMed         Abstract available
    
    

    
    J Hepatol

36. KOH JY, Rha MS, Choi SJ, Lee HS, et al
    Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner.
    J Hepatol. 2022 May 26. pii: S0168-8278(22)00335.
    PubMed         Abstract available
    
    
37. POURIKI S, Alexopoulos T, Vasilieva L, Vrioni G, et al
    Rectal colonization by resistant bacteria is associated with infection by the colonizing strain and high mortality in decompensated cirrhosis.
    J Hepatol. 2022 May 25. pii: S0168-8278(22)00328.
    PubMed        
    
    
38. YOO S, Kim JY, Lim YS, Han S, et al
    Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    J Hepatol. 2022 May 25. pii: S0168-8278(22)00329.
    PubMed         Abstract available
    
    
39. DING WX, Ni HM, Waguri S, Komatsu M, et al
    Lack of Hepatic Autophagy Promotes Severity of Liver Injury but Not Steatosis.
    J Hepatol. 2022 May 25. pii: S0168-8278(22)00330.
    PubMed        
    
    
40. MOLINA L, Zhu J, Trepo E, Bayard Q, et al
    Biallelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.
    J Hepatol. 2022 May 27. pii: S0168-8278(22)00333.
    PubMed         Abstract available
    
    

    
    PLoS One

41. BESSHO R, Kashiwagi K, Ikura A, Yamataka K, et al
    A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.
    PLoS One. 2022;17:e0269265.
    PubMed         Abstract available
    
    
42. WANG L, Ding Y, Zhang C, Chen R, et al
    Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
    PLoS One. 2022;17:e0269249.
    PubMed         Abstract available
    
    
43. THEVENOT T, Vendeville S, Weil D, Akkouche L, et al
    Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study.
    PLoS One. 2022;17:e0266965.
    PubMed         Abstract available
    
    
44. LAUN FB, Fuhres T, Seuss H, Muller A, et al
    Flow-compensated diffusion encoding in MRI for improved liver metastasis detection.
    PLoS One. 2022;17:e0268843.
    PubMed         Abstract available
    
    

    
    Transplant Proc

45. PAWLICKI J, Kurek A, Krol R
    Evaluation of Early and Late Effects of Surgical Treatment of Early Hepatic Artery Thrombosis After Liver Transplantation.
    Transplant Proc. 2022 May 29. pii: S0041-1345(22)00290.
    PubMed         Abstract available
    
    
46. GRECA RD, Cunha-Silva M, Mazo DF, Costa LBE, et al
    Prevalence of Hepatocellular Carcinoma and Its Characteristics in 10 Years of Transplantation in a University Hospital in Brazil.
    Transplant Proc. 2022 May 25. pii: S0041-1345(22)00272.
    PubMed         Abstract available
    
    

    
    Transplantation

47. CROOME KP, Mathur AK, Aqel B, Yang L, et al
    Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort.
    Transplantation. 2021 Aug 30. pii: 00007890-900000000-95163.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: